Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies

Oncology Letters

Volumn 9, Issue 3, 2015, Pages 1307-1312

  Zhang, Xiaoyi ^a   Zhou, Guiqin ^b   Sun, Bo ^a   Zhao, Guohua ^a   Liu, Dezhong ^a   Sun, Jiage ^a   Liu, Chuanhai ^a   Guo, Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Incidence; Meta analysis; Mortality; Obesity; Prospective cohort studies; Prostate cancer

Indexed keywords

ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CELL HETEROGENEITY; CONFIDENCE INTERVAL; DISEASE ASSESSMENT; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; NEWCASTLE OTTAWA SCALE; OBESITY; PROSTATE CANCER; RISK FACTOR;

EID: 84921759447     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2841     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Saad F and Pantel K: The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncol 8: 321-331, 2012.
3. Pontes-Júnior J, Reis ST, et al: Association between integrin expression and prognosis in localized prostate cancer. Prostate 70: 1189-1195, 2010.
4. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks Geneva, World Health Organization 2009. http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf. Accessed March 19, 2013.
5. Wang YC, McPherson K, Marsh T, Gortmaker SL and Brown M: Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378: 815-825, 2011.
6. Freedland SJ, Bañez LL, Sun LL,et al: Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis 12: 259-263, 2009.
7. Cao Y and Ma J: Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 4: 486-501, 2011.
8. Mallah KN, DiBlasio CJ, Rhee AC, et al: Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy. Cancer 103: 2030-2034, 2005.
9. Discacciati A, Orsini N and Wolk A: Body mass index and incidence of localized and advanced prostate cancer - a dose-response meta-analysis of prospective studies. Ann Oncol 23: 1665-1671, 2012.
10. Stroup DF, Berlin JA, Morton SC, et al: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012, 2000.
11. Cota GF, de Sousa MR, Fereguetti TO and Rabello A: Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison. PLoS Negl Trop Dis 7: e2195, 2013.
12. Zwahlen M, Renehan A and Egger M: Meta-analysis in medical research: potentials and limitations. Urol Oncol 26: 320-329, 2008.
13. Häggström C, Stocks T, Ulmert D, et al: Prospective study on metabolic factors and risk of prostate cancer. Cancer 118: 6199-6206, 2012.
14. Bassett JK, Severi G, Baglietto L, et al: Weight change and prostate cancer incidence and mortality. Int J Cancer 131: 1711-1719, 2012.
15. Dehal A, Garrett T, Tedders SH, et al: Body mass index and death rate of colorectal cancer among a national cohort of U.S. adults. Nutr Cancer. 63: 1218-1225, 2011.
16. Burton A, Martin R, Galobardes B, et al: Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control 21: 2069-2077, 2010.
17. Stocks T, Hergens MP, Englund A, Ye W and Stattin P: Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 127: 1660-1668, 2010.
18. Pischon T, Boeing H, Weikert S, et al: Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 17: 3252-3261, 2008.
19. Giovannucci E, Liu Y, Platz EA, Stampfer MJ and Willett WC: Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 121: 1571-1578, 2007.
20. Littman AJ, White E and Kristal AR: Anthropometrics and prostate cancer risk. Am J Epidemiol 165: 1271-1279, 2007.
21. Wright ME, Chang SC, Schatzkin A, et al: Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109: 675-684, 2007.
22. Engeland A, Tretli S and Bjørge T: Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 89: 1237-1242, 2003.
23. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003.
24. Rodriguez C, Patel AV, Calle EE, et al: Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10: 345-353, 2001.
25. Andersson SO, Wolk A, Bergström R, et al: Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89: 385-389, 1997.
26. Schuurman AG, Goldbohm RA, Dorant E and van den Brandt PA: Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151: 541-549, 2000.
27. Lee IM, Sesso HD and Paffenbarger RS Jr: A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control 12: 187-193, 2001.
28. + Rural Health Study (United States). Cancer Causes Control 8: 229-238, 1997.
29. Hajian-Tilaki KO, Gholizadehpasha AR, Bozorgzadeh S and Hajian-Tilaki E: Body mass index and waist circumference are predictor biomarkers of breast cancer risk in Iranian women. Med Oncol 28: 1296-1301, 2011.
30. Puente Vazquez J, Grande Pulido E and Anton Aparicio LM: Cytokine and endocrine signaling in prostate cancer. Med Oncol 29: 1956-1963, 2012.
31. MacInnis RJ and English DR: Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17: 989-1003, 2006.
32. Baillargeon J, Platz EA, Rose DP, et al: Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev 15: 1331-1335, 2006.
33. Porter MP and Stanford JL: Obesity and the risk of prostate cancer. Prostate 62: 316-321, 2005.
34. Gong Z, Neuhouser ML, Goodman PJ, et al: Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15: 1977-1983, 2006.
35. Rodriguez C, Freedland SJ, Deka A, et al: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16: 63-69, 2007.
36. Roberts DL, Dive C and Renehan AG: Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61: 301-316, 2010.
37. Hu Q, Gou Y, Sun C, et al: The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol 32: 50.e1-50.e8, 2014.